- Home
- CALC vs GFAI Comparison
CALC vs GFAI Comparison
Compare CALC & GFAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CALC
- GFAI
- Stock Information
- Founded
- CALC 2011
- GFAI 2018
- Country
- CALC United States
- GFAI Singapore
- Employees
- CALC N/A
- GFAI N/A
- Industry
- CALC Biotechnology: Pharmaceutical Preparations
- GFAI Diversified Commercial Services
- Sector
- CALC Health Care
- GFAI Consumer Discretionary
- Exchange
- CALC Nasdaq
- GFAI Nasdaq
- Market Cap
- CALC 20.9M
- GFAI 20.7M
- IPO Year
- CALC N/A
- GFAI N/A
- Fundamental
- Price
- CALC $1.91
- GFAI $1.08
- Analyst Decision
- CALC Strong Buy
- GFAI Strong Buy
- Analyst Count
- CALC 3
- GFAI 1
- Target Price
- CALC $16.33
- GFAI $4.50
- AVG Volume (30 Days)
- CALC 33.2K
- GFAI 259.4K
- Earning Date
- CALC 05-14-2025
- GFAI 04-28-2025
- Dividend Yield
- CALC N/A
- GFAI N/A
- EPS Growth
- CALC N/A
- GFAI N/A
- EPS
- CALC N/A
- GFAI N/A
- Revenue
- CALC N/A
- GFAI $36,347,373.00
- Revenue This Year
- CALC N/A
- GFAI $5.66
- Revenue Next Year
- CALC N/A
- GFAI $4.69
- P/E Ratio
- CALC N/A
- GFAI N/A
- Revenue Growth
- CALC N/A
- GFAI 0.18
- 52 Week Low
- CALC $1.43
- GFAI $0.76
- 52 Week High
- CALC $6.02
- GFAI $3.88
- Technical
- Relative Strength Index (RSI)
- CALC 56.52
- GFAI 53.61
- Support Level
- CALC $1.86
- GFAI $1.00
- Resistance Level
- CALC $2.04
- GFAI $1.18
- Average True Range (ATR)
- CALC 0.14
- GFAI 0.07
- MACD
- CALC 0.05
- GFAI 0.01
- Stochastic Oscillator
- CALC 64.79
- GFAI 47.37
About CALC CalciMedica Inc.
CalciMedica Inc is a clinical-stage biopharmaceutical company focused on developing therapeutics that treat serious illnesses driven by inflammatory and immunologic processes and direct cellular damage. Its product candidates act upon calcium release-activated calcium (CRAC) channels and would constitute a new class of drugs. Its product candidate is Auxora, a potent and selective intravenous formulated small molecule CRAC channel inhibitor containing the active compound zegocractin (formerly referred to as CM4620) that, in animal models, reduced acute epithelial and/or endothelial cell injury and inflammation in organs, such as the pancreas, lungs and kidneys.
About GFAI Guardforce AI Co. Limited
Guardforce AI Co Ltd is a provider of cash solutions and cash handling services located in Thailand. The company engages in the cash logistics business, and its services include cash-in-transit, or CIT, dedicated vehicles to banks, ATM management, cash center operations, cash processing, coin processing, cheque center, and cash deposit machine solutions (cash deposit management and express cash service). Its customers include local commercial banks, chain retailers, coin-manufacturing mints, and government authorities.